Open Access
CC BY 4.0 · Synlett 2025; 36(10): 1371-1374
DOI: 10.1055/a-2535-1219
letter

Divergent Two-Step Total Synthesis of Sclerotioloid A and B

Authors


J.H.S acknowledges funding from Aalto University, FinnCERES, and the Research Council of Finland (project 354458).


Graphical Abstract

Abstract

A two-step divergent total synthesis of the structurally unique N-propargylated alkaloids sclerotioloid A and B has been achieved. The synthesis relies on a robust aldol-propargylation domino reaction yielding the key divergent intermediate. Single-crystal X-ray structure studies of the natural product sclerotioloid A show that it exists as a helically chiral racemate in the solid state.

Supporting Information



Publication History

Received: 15 July 2024

Accepted after revision: 27 January 2025

Accepted Manuscript online:
07 February 2025

Article published online:
12 May 2025

© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by/4.0/)

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

 
  • References and Notes

  • 1 Borthwick AD. Chem. Rev. 2012; 112: 3641
  • 2 Mao JQ, Zheng Y.-Y, Wang C.-Y, Liu Y, Yao G.-S. Mar. Drugs 2023; 21: 219
  • 3 Li X, Lv JM, Hu D, Abe I. RSC Chem. Biol. 2021; 2: 166
  • 4 Narcis MJ, Takenaka N. Eur. J. Org. Chem. 2014; 21
  • 5 Liu M, Zhang L, Wang T. Chem. Rev. 2015; 115: 7304
  • 7 Liao SR, Du LJ, Qin XC, Xu L, Wang JF, Zhou XF, Tu ZC, Li J, Liu YH. Tetrahedron 2016; 72: 1051
  • 8 ( Z)-1-Acetyl-3-benzylidene-4-(prop-2-yn-1-yl)piperazine-2,5-dione (3): A mixture of 4 (200 mg, 1.01 mmol, 1.00 equiv), Cs2CO3 (822 mg, 2.52 mmol, 2.50 equiv), benzaldehyde (6, 0.11 mL, 1.11 mmol, 1.10 equiv, vacuum distilled), propargyl bromide (5, 0.38 mL, 5.05 mmol, 5.00 equiv) and flame-dried 4 Å MS (840 mg, 425 wt-%) in anhydrous DMF (8 mL) was stirred at room temperature for 2 h under argon. The resulting brown suspension was concentrated under reduced pressure followed by addition of DI water (50 mL) and EtOAc (25 mL). The layers were separated, and the aqueous layer was extracted with EtOAc (3 × 20 mL). The combined organic layers were washed with brine (10 mL), dried with Na2SO4, and concentrated in vacuo. The thus obtained crude product was purified using flash column chromatography (SiO2, 30% EtOAc/Hexane) to yield 3 as a yellow crystalline solid (166 mg, 58%). Rf 0.29 (25% EtOAc/Hex; UV, KMnO4); mp 173.1–174.0 °C. 1H NMR (400 MHz, CDCl3): δ = 7.45 (s, 1 H), 7.43–7.36 (m, 5 H), 4.56 (s, 2 H), 4.27 (d, J = 2.5 Hz, 2 H), 2.65 (s, 3 H), 2.14 (t, J = 2.5 Hz, 1 H). {1H}13C NMR (101 MHz, CDCl3): δ = 171.6, 164.7, 164.1, 132.5, 130.0, 129.6, 129.05, 128.95, 127.8, 77.0, 73.1, 45.3, 33.8, 26.8. FTIR (ATR): 2921, 2851, 1698, 1628, 1354, 1192, 936, 743 cm–1. HRMS (ESI+): m/z [M+Na+] calcd. for C16H14N2O3: 305.0897; found: 305.0899.
  • 9 CCDC 2338001 contains the supplementary crystallographic data for 3. The data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/structures
  • 11 Sclerotioloid A (1): To a stirred suspension of 3 (20 mg, 1.0 equiv) in MeOH (1 mL), hydrazine hydrate (60 μL, 62 mmol, 80% v/v solution in water, 22 equiv) was added. The resulting suspension was stirred at room temperature for 5 min. TLC showed full conversion and all material had dissolved. The reaction mixture was concentrated in vacuo and purified using flash column chromatography (SiO2, 75% EtOAc/Hexane) to yield sclerotioloid A (1) as a white solid (14.3 mg, 84%). Spectroscopic data matched those reported previously.2 Rf 0.29 (25% EtOAc/Hex; UV, KMnO4). 1H NMR (400 MHz, CDCl3): δ = 8.42 (s, 1 H), 7.46–7.35 (m, 5 H), 4.56 (s, 2 H), 4.27 (d, J = 2.5 Hz, 2 H), 2.65 (s, 3 H), 2.14 (t, J = 2.5 Hz, 1 H). {1H}13C NMR (101 MHz, CDCl3): δ = 171.6, 164.7, 164.1, 132.5, 130.0, 129.6, 129.05, 128.95, 127.8, 77.0, 73.1, 45.3, 33.8, 26.8.
  • 12 Sclerotioloid B (2): A solution of 3 (32 mg, 0.113 mmol, 1.00 equiv) in anhydrous MeOH (2 mL) was stirred at 50 °C for 2 days. The reaction mixture was concentrated in vacuo and purified using flash column chromatography (SiO2, EtOAc) to yield sclerotioloid B (2) as a white crystalline solid (11.7 mg, 33%). Spectroscopic data matched those reported previously.2 Rf 0.16 (75% EtOAc/Hex; UV, KMnO4). 1H NMR (400 MHz, DMSO-d 6): δ = 8.06 (t, J = 5.58 Hz, 1 H), 7.85 (s, 1 H), 7.75 (d, J = 1.2 Hz, 1 H), 7.73 (d, J = 1.8 Hz, 1 H), 7.45–7.50 (m, 3 H), 4.38 (dd, J = 17.6 Hz, 2.6 Hz, 1 H), 4.25 (dd, J = 17.6 Hz, 2.6 Hz, 1 H), 3.81 (s, 3 H), 3.67 (dd, J = 17.0 Hz, 5.7 Hz, 1 H), 3.56 (dd, J = 17.0 Hz, 5.6 Hz, 1 H), 3.14 (t, J = 2.6 Hz, 1 H), 1.77 (s, 3 H). {1H}13C NMR (101 MHz, DMSO-d6): δ = 169.3, 168.7, 164.7, 139.7, 131.8, 131.3, 130.5, 129.1, 126.9, 77.8, 76.1, 52.8, 40.7, 35.8, 22.2.
  • 14 CCDC 2338002 contains the supplementary crystallographic data for 1. The data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/structures